Dupont Capital Management Corp Abbott Laboratories Transaction History

Dupont Capital Management Corp

$889 Million
Q1 2025

A detailed history of Dupont Capital Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Dupont Capital Management Corp holds 89,853 shares of ABT stock, worth $11.6 Million. This represents 1.34% of its overall portfolio holdings.

Number of Shares

89,853

Previous 109,575 18.0%

Holding current value

$11.6 Million

Previous $12.4 Million 3.83%

% of portfolio

1.34%

Previous 1.17%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 21, 2025	SELL	$111.1 - $140.22 $2.19 Million - $2.77 Million	-19,722 Reduced 18.0%	89,853 $11.9 Million
Q2 2024 Jul 18, 2024	SELL	$100.73 - $112.44 $645,679 - $720,740	-6,410 Reduced 5.53%	109,575 $11.4 Million
Q1 2024 Apr 23, 2024	SELL	$109.52 - $120.96 $859,732 - $949,536	-7,850 Reduced 6.34%	115,985 $13.2 Million
Q4 2023 Jan 23, 2024	SELL	$90.19 - $110.4 $290,501 - $355,598	-3,221 Reduced 2.54%	123,835 $13.6 Million
Q3 2023 Oct 27, 2023	BUY	$95.53 - $114.62 $7.89 Million - $9.47 Million	82,579 Added 185.67%	127,056 $12.3 Million
Q2 2023 Jul 25, 2023	SELL	$100.78 - $112.29 $75,181 - $83,768	-746 Reduced 1.65%	44,477 $4.85 Million
Q1 2023 Apr 28, 2023	BUY	$96.86 - $114.01 $915,617 - $1.08 Million	9,453 Added 26.43%	45,223 $4.58 Million
Q4 2022 Jan 26, 2023	SELL	$95.06 - $111.52 $643,556 - $754,990	-6,770 Reduced 15.91%	35,770 $0
Q3 2022 Oct 31, 2022	SELL	$96.76 - $112.03 $3.45 Million - $3.99 Million	-35,615 Reduced 45.57%	42,540 $4.12 Million
Q2 2022 Jul 26, 2022	SELL	$102.07 - $123.37 $702,649 - $849,279	-6,884 Reduced 8.1%	78,155 $8.49 Million
Q1 2022 Apr 27, 2022	BUY	$114.02 - $139.04 $31,469 - $38,375	276 Added 0.33%	85,039 $10.1 Million
Q4 2021 Jan 31, 2022	SELL	$115.53 - $141.46 $3.42 Million - $4.19 Million	-29,592 Reduced 25.88%	84,763 $11.9 Million
Q3 2021 Nov 03, 2021	BUY	$116.66 - $129.06 $756,306 - $836,695	6,483 Added 6.01%	114,355 $13.5 Million
Q2 2021 Jul 30, 2021	SELL	$105.79 - $124.53 $2.85 Million - $3.36 Million	-26,965 Reduced 20.0%	107,872 $12.5 Million
Q1 2021 Apr 29, 2021	SELL	$108.84 - $128.23 $3.28 Million - $3.86 Million	-30,138 Reduced 18.27%	134,837 $16.2 Million
Q4 2020 Jan 28, 2021	SELL	$105.0 - $114.42 $2.38 Million - $2.6 Million	-22,696 Reduced 12.09%	164,975 $18.1 Million
Q3 2020 Oct 29, 2020	SELL	$91.64 - $111.29 $335,219 - $407,098	-3,658 Reduced 1.91%	187,671 $20.4 Million
Q2 2020 Jul 24, 2020	BUY	$76.57 - $98.0 $5.56 Million - $7.11 Million	72,561 Added 61.09%	191,329 $17.5 Million
Q1 2020 Apr 29, 2020	BUY	$62.82 - $91.86 $2.68 Million - $3.91 Million	42,590 Added 55.91%	118,768 $9.37 Million
Q4 2019 Jan 27, 2020	SELL	$78.51 - $87.4 $3.13 Million - $3.49 Million	-39,903 Reduced 34.38%	76,178 $6.62 Million
Q3 2019 Oct 28, 2019	SELL	$81.84 - $88.74 $4.9 Million - $5.31 Million	-59,888 Reduced 34.03%	116,081 $9.71 Million
Q2 2019 Jul 30, 2019	BUY	$72.88 - $85.0 $850,290 - $991,695	11,667 Added 7.1%	175,969 $14.8 Million
Q1 2019 Apr 30, 2019	SELL	$66.22 - $80.06 $6.06 Million - $7.33 Million	-91,518 Reduced 35.77%	164,302 $13.1 Million
Q4 2018 Feb 01, 2019	SELL	$65.56 - $74.27 $1.05 Million - $1.19 Million	-16,048 Reduced 5.9%	255,820 $18.5 Million
Q3 2018 Nov 05, 2018	SELL	$60.81 - $73.36 $6.3 Million - $7.6 Million	-103,577 Reduced 27.59%	271,868 $19.9 Million
Q2 2018 Jul 30, 2018	BUY	$57.57 - $63.54 $59,987 - $66,208	1,042 Added 0.28%	375,445 $22.9 Million
Q1 2018 May 02, 2018	BUY	$56.27 - $63.62 $2.31 Million - $2.61 Million	41,015 Added 12.3%	374,403 $22.4 Million
Q4 2017 Jan 31, 2018	BUY	$53.68 - $57.47 $7.62 Million - $8.16 Million	141,973 Added 74.17%	333,388 $19 Million
Q3 2017 Oct 31, 2017	BUY	$48.06 - $53.64 $9.2 Million - $10.3 Million	191,415	191,415 $10.2 Million

Others Institutions Holding ABT

# of Institutions

3,440

Shares Held

1.34B

Call Options Held

10.5M

Put Options Held

8.72M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Account

Dupont Capital Management Corp Abbott Laboratories Transaction History